Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

Presentation TCT 2025

Optimizing PCI Outcomes After ACS: Anti-Inflammatory Therapies - unCLEAR SYNERGies?

Presenter: Sanjit S. Jolly

October 27, 2025

Presentation TCT 2025

TCT 774: Anti-inflammatory Nanoparticles for Enhanced Treatment of Peripheral Arterial Disease

Presenter: Richard Tan

October 26, 2025

Presentation TCT 2025

ACS Pharma Trials On The Horizon: Addressing The Anti-inflammatory Cascade

Presenter: Duk-Woo Park

October 26, 2025

News Conference News TCT 2024

Co-STAR Hints That Colchicine May Curb Rhythm Disturbances After TAVI

Michael O'Riordan

November 06, 2024

News Conference News TCT 2024

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

Michael O'Riordan

October 29, 2024

Presentation TCT 2024

Beyond Antithrombotics: Lipid-Lowering and Anti-Inflammatory Therapies Post MI

Presenter: Jennifer Rymer

October 29, 2024

Presentation TCT 2022

New and Emerging Pharmacology for ACS: Lipid Modulation and Anti-Inflammatory Agents

Presenter: Sanjit Jolly

September 19, 2022

News Conference News TCT 2020

Icosapent Ethyl’s Benefits Consistent in Patients With Prior PCI: REDUCE-IT

Todd Neale

October 21, 2020

Off Script: A (Not So) Brief History of Aspirin’s Rise and Fall

News Opinion Off Script TCT 2019

Off Script: The TWILIGHT of Aspirin? A Brief History of ASA’s Rise and Fall

Kwan S. Lee

September 29, 2019

News Conference News TCT 2018

Statin Preloading Benefit More Pronounced in STEMI Patients: SECURE-PCI

Michael O'Riordan

October 05, 2018

News Conference News TCT 2018

Next Steps With NIRS: Lipid-Rich Plaque Study Shows Promise Identifying High-Risk Patients, Plaques

Yael L. Maxwell

September 24, 2018

Presentation TCT 2017

Keynote Lecture: Personalized Treatment of the Vulnerable Patient With PCSK9 Inhibitors, Anti-inflammatory Therapies and CTEP Inhibitors

Presenter: Gregg W. Stone, Peter H. Stone, Evan A. Stein

November 01, 2017

Presentation TCT 2016

Are PCSK9 Inhibitors and Anti-inflammatory Therapies for Vulnerable Plaque Right Around the Corner?

Presenter: Gregg W. Stone, Ron Waksman, Sanjit S. Jolly

November 01, 2016

Presentation TCT 2016

Anti-inflammatory Therapies for Atherosclerosis

Presenter: Robert A. Harrington, A. Michael Lincoff, Jean-Claude Tardif

October 30, 2016

Presentation TCT 2013

Abluminal- Only Coating Everolimus Eluting Coronary Stent Provides an Anti-inflammatory Vascular Effect Compared to Bare Metal Stents in the Familial Hypercholesterolemic Swine

Presenter: Armando Tellez, Elina Donskoy, Natalia Sushkova, Paul Seifert, Taylor Palmieri, William Rate, Samantha Stone, Michael Eppihimer, Greg Kaluza, Barbara Huibregtse, Keith Dawkins, Juan Granada

January 31, 2013

Presentation TCT 2012

Anti-inflammatory Effect of Arsenic Trioxide Eluting Stents in a porcine coronary model

Presenter: Li Shen, Wei Yang, Feirong Gong, Yizhe Wu, Juying Qian, Aijun Sun, Yunzeng Zou, Junbo Ge

January 03, 2012

Advertisement

Optimizing PCI Outcomes After ACS: Anti-Inflammatory Therapies - unCLEAR SYNERGies?

TCT 774: Anti-inflammatory Nanoparticles for Enhanced Treatment of Peripheral Arterial Disease

ACS Pharma Trials On The Horizon: Addressing The Anti-inflammatory Cascade

Co-STAR Hints That Colchicine May Curb Rhythm Disturbances After TAVI

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

Beyond Antithrombotics: Lipid-Lowering and Anti-Inflammatory Therapies Post MI

New and Emerging Pharmacology for ACS: Lipid Modulation and Anti-Inflammatory Agents

Icosapent Ethyl’s Benefits Consistent in Patients With Prior PCI: REDUCE-IT

Off Script: The TWILIGHT of Aspirin? A Brief History of ASA’s Rise and Fall

Statin Preloading Benefit More Pronounced in STEMI Patients: SECURE-PCI

Next Steps With NIRS: Lipid-Rich Plaque Study Shows Promise Identifying High-Risk Patients, Plaques

Keynote Lecture: Personalized Treatment of the Vulnerable Patient With PCSK9 Inhibitors, Anti-inflammatory Therapies and CTEP Inhibitors

Are PCSK9 Inhibitors and Anti-inflammatory Therapies for Vulnerable Plaque Right Around the Corner?

Anti-inflammatory Therapies for Atherosclerosis

Abluminal- Only Coating Everolimus Eluting Coronary Stent Provides an Anti-inflammatory Vascular Effect Compared to Bare Metal Stents in the Familial Hypercholesterolemic Swine

Anti-inflammatory Effect of Arsenic Trioxide Eluting Stents in a porcine coronary model

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content